OmniActive Health Technologies today announced the launch of Lutemax 2020(TM), a next generation eye health ingredient that combines the most studied and recognized ingredients for vision support – lutein and zeaxanthin isomers.
The human eye contains lutein and zeaxanthin isomers, namely RR zeaxanthin and RS zeaxanthin, which have been researched for their key role in protecting against Age-related Macular Degeneration.
Unfortunately, a vast majority of lutein products currently on the market contain very low levels of zeaxanthin. Lutemax 2020 is the first ingredient that provides enhanced levels of zeaxanthin isomers, along with lutein, for convenient and more beneficial nutrient availability to the eyes.
“Eye health is of the utmost importance to all individuals, especially aging boomers, and as the vision health supplement category continues to grow, we are confident that Lutemax 2020 will take center-stage,” stated Dr. Jayant Deshpande, Chief Technology Officer, OmniActive Health Technologies. “Lutemax 2020 allows manufacturers to create new nutritional formulations or update their existing eye health product offerings with an ingredient that delivers nutritionally relevant, enhanced levels of zeaxanthin isomers with lutein, at an affordable cost-in-use. And formulators will enjoy the fact that upgrading to Lutemax 2020 is nearly effortless.” Read the full Story at NPI Center